natgillin/translations-raw huggingface dataset:
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Vyndaqel have also been included in the summary of product characteristics and the package leaflet. 
Priporočila in previdnostni ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki za varno in učinkovito uporabo tega zdravila so prav tako vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
Vyndaqel has been authorised under ‘exceptional circumstances'. 
Zdravilo Vyndaqel je pridobilo dovoljenje za promet „v izjemnih okoliščinah“.
The summary of the opinion of the Committee for Orphan Medicinal Products for Vyndaqel can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/Rare disease designations. 
Povzetek mnenja Odbora za zdravila sirote o zdravilu Vyndaqel je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/Rare disease designations.
It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Vyndaqel. 
Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil to zdravilo, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
The most common side effects with Vyndaqel (seen in more than 1 patient in 10) are urinary tract infection (infection of the structures that carry urine), vaginal infection, upper abdominal pain (stomach ache) and diarrhoea. 
Najpogostejši neželeni učinki zdravila Vyndaqel (opaženi pri več kot 1 bolniku od 10) so vnetje sečil (okužba struktur za odvajanje seča), vnetje nožnice, bolečine v zgornjem delu trebuha (bolečine v želodcu) in driska.
The CHMP therefore concluded that the benefits of Vyndaqel are greater than its risks and recommended that it be granted marketing authorisation. 
CHMP je zaključil, da so koristi zdravila Vyndaqel večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
The full EPAR for Vyndaqel can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports. 
Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Vyndaqel je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
In patients with transthyretin amyloidosis, a blood protein called transthyretin is defective and breaks easily. 
Pri bolnikih s transtiretinsko amiloidozo je krvna beljakovina, imenovana transtiretin, poškodovana in hitro razpade.
The broken protein forms a fibrous substance called amyloid that is deposited in tissues and organs around the body, including around nerves, where it interferes with their normal functions. 
Razgrajena beljakovina tvori vlaknasto snov, imenovano amiloid, ki se odlaga v tkivih in organih po vsem telesu, vključno okoli živcev, kjer moti njihovo normalno delovanje.
Vyndaqel is used in adult patients with the early stage of nerve disease (stage 1). 
Uporablja se pri odraslih bolnikih z zgodnjo stopnjo živčnega obolenja (stopnja 1).
The company that markets Vyndaqel will provide educational material to all doctors expected to prescribe Vyndaqel. 
Družba, ki trži zdravilo Vyndaqel, bo vsem zdravnikom, ki naj bi ga predpisovali, priskrbela ustrezno izobraževalno gradivo.
For the full list of all side effects and restrictions with Vyndaqel, see the package leaflet. 
Za celoten seznam vseh neželenih učinkov in omejitev pri uporabi zdravila Vyndaqel glejte navodilo za uporabo.
Because the number of patients with transthyretin amyloidosis is low, the disease is considered ‘rare', and Vyndaqel was designated an ‘orphan medicine' (a medicine used in rare diseases) on 28 August 
Ker je bolnikov s transtiretinsko amiloidozo malo, velja ta bolezen za redko, zato je bilo zdravilo Vyndaqel 28. avgusta 2006 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
What benefit has Vyndaqel shown during the studies? 
Kakšne koristi je zdravilo Vyndaqel izkazalo med študijami?
Vyndaqel is a medicine that contains the active substance tafamidis. 
Vyndaqel je zdravilo, ki vsebuje zdravilno učinkovino tafamidis.
Other information about Vyndaqel 
Druge informacije o zdravilu Vyndaqel
It attaches to transthyretin, which prevents the protein from breaking up, thereby stopping the formation of amyloid and slowing down the progression of the nerve disease. 
Z vezavo na transtiretin prepreči njegovo razgradnjo, s čemer se ustavi tvorba amiloida in upočasni napredovanje obolenja živcev.
The active substance in Vyndaqel, tafamidis, is a transthyretin stabilizer. 
Zdravilna učinkovina zdravila Vyndaqel, tafamidis, je stabilizator transtiretina.
Vyndaqel is used to delay nerve damage caused by transthyretin amyloidosis, a hereditary disease in which fibres called amyloid build up in tissues around the body including around the nerves. 
Zdravilo Vyndaqel se uporablja za upočasnitev napredovanja poškodbe živcev, ki jo povzroča transtiretinska amiloidoza, tj. dedna bolezen, pri kateri se amiloidna vlakna kopičijo v tkivih po telesu, vključno okoli živcev.
Vyndaqel was more effective than placebo at treating patients with transthyretin amyloidosis. 
Zdravilo Vyndaqel je bilo učinkovitejše od placeba pri zdravljenju bolnikov s transtiretinsko amiloidozo.
Vyndaqel was compared with placebo (a dummy treatment) in 128 patients with transthyretin amyloidosis. 
Zdravilo Vyndaqel so primerjali s placebom (zdravilom brez zdravilne učinkovine) pri 128 bolnikih s transtiretinsko amiloidozo.
What is the risk associated with Vyndaqel? 
Kakšna tveganja so povezana z zdravilom Vyndaqel?
What information is still awaited for Vyndaqel? 
Katere informacije o zdravilu Vyndaqel še pričakujemo?
Why has Vyndaqel been approved? 
Zakaj je bilo zdravilo Vyndaqel odobreno?
The CHMP noted that, apart from in patients who left the study because they needed a liver transplant, Vyndaqel was more effective than placebo in delaying nerve damage in patients with transthyretin amyloidosis. 
Odbor za zdravila za uporabo v humani medicini (CHMP) je menil, da se je zdravilo Vyndaqel pri bolnikih s transtiretinsko amiloidozo razen bolnikov, ki so študijo predčasno zapustili, ker so potrebovali presaditev jeter, izkazalo za učinkovitejše od placeba pri upočasnitvi napredovanja poškodbe živcev.
How is Vyndaqel used? 
Kako se zdravilo Vyndaqel uporablja?
How has Vyndaqel been studied? 
Kako je bilo zdravilo Vyndaqel raziskano?
How does Vyndaqel work? 
Kako zdravilo Vyndaqel deluje?
What is Vyndaqel? 
Kaj je zdravilo Vyndaqel?
20 mg/ml Solution for injection 
20 mg/ml raztopina za injiciranje subkutana uporaba viala (steklo)
Pack size 
Mozobil
2 As lower confidence limit (p = 0.95) 
2 Kot spodnja meja zaupanja (p = 0,95)
_*_One 2-ml dose contains: rotavirus serotype* G1 
_*_ En 2-ml odmerek vsebuje: G1 serotip* rotavirusa
not less than 2.3 x 106 IU1, 2 * human-bovine rotavirus reassortants (live), produced in Vero cells. 
P1[8] serotip* rotavirusa ne manj kot 2,3 x 106 IE1, 2 * prerazporejeni humano-bovini rotavirusi (živi), pridobljeni na celicah Vero 1 Infektivnih enot
Invented name Strength Pharmaceutical Form 
Številka EU Izmišljeno ime Jakost Farnacevtska oblika Pot uporabe
Content 
Ovojnina Vsebina
Regulation 1530/02 / OJL230 of 28 August 2002 
Uredba 1530/02 / OJL230 z dne 28. avgusta 2002
Gonazon for fish: 
Gonazon za ribe:
No antidotes are available. 
Protistrupov ni na voljo.
Fish should be anaesthetised. 
Ribe je treba anestezirati.
Withdraw the needle from the skin. 
Izvlecite iglo iz kože.
Do not store above 25C. 
Ne shranjujte pri temperaturi nad 25 C.
Position the bitch on her back. 
Psico namestimo na hrbet.
The recommended dose is 32 µg/kg body weight. 
Priporočeni odmerek je 32 µg/kg telesne mase.
Benzyl alcohol (1%) 
Benzilni alkohol (1 %)
The transition between the stimulatory and inhibitory effects is completed within approximately one month. 
Prehod od stimulativnega do zaviralnega delovanja se zaključi približno v enem mesecu.
It is recommended to strip fish after injection at intervals of approximately 50-100 degree days. 
Ribe je po injekciji priporočljivo smukati v presledkih po približno 50-100 dnevnih stopinj.
In some cases this can be related to the use of the compound too early in the spawning season. 
To je včasih lahko posledica prezgodnje uporabe spojine v sezoni mrestenja.
Additional sterile vials will be supplied on request. 
Dodatne sterilne viale so na voljo po naročilu.
This brief phase may result in induced heat within one to four weeks following the first administration of the implant (see section 4.5). 
Posledica te kratke faze je lahko indukcija gonitve v enem do štirih tednih po prvi uporabi implantata (glejte poglavje 4.5).
Gonazon for dogs: Intervet GesmbH Siemensstrasse 107 A-1210 Wien Austria 
Gonazon za pse: Intervet GesmbH Siemensstrasse 107 A-1210 Wien Avstrija
REMOVAL: 
ODSTRANITEV:
Do not use in bitches (prepubertal and adult) intended for breeding (see section 4.7). 
Ne uporabite pri psicah (pred puberteto in odraslih), namenjenih za vzrejo (glejte poglavje 4.7).
The risk of inducing a fertile heat is low in metoestrus (5%). 
Tveganje, da bi spodbudili fertilni estrus, je v metestrusu majhno (5 %).
The duration of prevention of gonadal function is obtained as detailed in the table below: 
Trajanje preprečevanja gonadne funkcije je navedeno v spodnji tabeli:
3 - 6 years old 
3 -6 let trajanje blokade
An overdose will not accelerate the onset or increase the degree of ovulation. 
Prevelik odmerek ne pospeši začetka ovulacije ali poveča njene stopnje.
For Arctic charr, injections should be given only if the water temperature is < 8°C. 
Jezerskim zlatovčicam smemo injekcije dajati samo pri temperaturi vode < 8 ºC.
Simultaneous administration of five implants during a oneyear period was well tolerated. 
Prenašanje sočasne uporabe petih implantatov v obdobju enega leta je bilo dobro.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable 
BESEDILO “SAMO ZA ŽIVALI” IN POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE, če je navedba smiselna
There are no data available for animals treated on more than two occasions. 
Ni na voljo podatkov o živalih, pri katerih bi izdelek uporabili več kot dvakrat.
The recommended dose is one implant per bitch. 
Priporočeni odmerek je en implantat za eno psico.
Inability to locate and remove Gonazon will not have serious effects on the general health of the dog. 
Če Gonazona ne najdemo in odstranimo, nima resnejših učinkov na splošno zdravje psice.
Water for injection 
voda za injekcije
Instruct the owner to keep the administration site clean and dry for 24 hours. 
Lastnika poučite, da mora biti mesto dajanja čisto in suho 24 ur.
Ensure that the administration site is clean and dry. 
Poskrbite, da bo mesto dajanja čisto in suho.
If the implant cannot be palpated in the month following administration, the owner is encouraged to seek veterinary advice as efficacy cannot be ensured in these cases. 
Če ga lastnik v mesecu po vnosu ne more otipati, naj se posvetuje z veterinarjem, ker v tem primeru učinkovitost ni zagotovljena.
Make a stab incision, approximately 5 mm long, along the elevated near end of the implant. 
Napravimo vbodni rez, približno 5 mm, vzdolž dvignjenega bližnjega konca implantata.
Keep out of the reach and sight of children. 
Zdravilo shranjujte izven dosega in pogleda otrok.
Sterile container: 50-ml empty 
Sterilni vsebnik: po 50 ml, prazen
Operators should wash their hands after use of the product. 
Osebe, ki uporabljajo izdelek, si morajo po uporabi umiti roke.
A large proportion (68%) of the first heat after a single treatment in adult bitches were non-ovulatory. 
Pri velikem deležu (68 %) prve gonitve po enkratni uporabi pri odraslih psicah ni prišlo do ovulacije.
At the end of a one year treatment, it may not be possible to locate and remove the implant in approximately 10% of cases. 
Po enem letu v približno 10 % primerov ne moremo določiti mesta implantata in ga odstraniti.
GnRH analogues are peptides. 
Analogi GnRH so peptidi.
The product is contraindicated in bitches intended for breeding (adult and prepubertal) as laboratory studies in which dogs received 3 simultaneous implants for a period of 12 months revealed a reduction in the numbers of live pups at whelping and weaning compared to an untreated control group. 
Zdravilo je kontraindicirano pri psicah, namenjenih za vzrejo (odraslih in pred puberteto), ker je bilo v laboratorijskih študijah, v katerih so psi sočasno prejeli 3 implantate v obdobju 12 mesecev, število živih mladičev ob kotitvi in odstavitvi manjše kot v nezdravljeni kontrolni skupini.
Therefore, if heat is observed, contact with male dogs should be prevented until all signs of heat (vulvar swelling, bleeding and attractiveness to male dogs) cease. 
Če se pojavi gonitev, moramo zato preprečiti stik s samci, dokler vsi znaki gonitve (nabreklo zunanje spolovilo, krvavitev in privlačnost za samce) ne minejo.
Do not mix with other medicinal products. 
Ne mešajte z drugimi zdravili.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/. 
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http://www.emea.europa.eu/.
Grasp it with forceps and remove. 
Primemo ga s pinceto in odstranimo.
In the absence of clinical information, do not treat bitches less than 3 kg bodyweight and bitches of giant breeds over 45 kg bodyweight. 
Ker ni na voljo kliničnih podatkov, ne uporabite pri psicah z manjšo telesno maso od 3 kg in pri zelo velikih pasmah s telesno maso nad 45 kg.
Preferred injection volume per kg fish (depending on fish 
Primeren injekcijski volumen na kg rib (glede na velikost
The product should not be used in fish maintained in water temperatures that would normally inhibit ovulation as this can result in a decrease in egg quality. 
Izdelka ne smemo uporabljati pri ribah, ki jih gojimo v vodi s temperaturo, katera bi normalno zavirala ovulacijo, ker se lahko zmanjša kakovost iker.
Administration of Gonazon at other stages of the cycle may induce heat that may be fertile. 
Uporaba Gonazona v drugih obdobjih cikla lahko spodbudi gonitev, ki je fertilna.
The method of administration is as follows: 
Dajemo ga po naslednji metodi:
Intraperitoneal (IP) use 
Intraperitonealna (i.p.)
Separate empty sterile containers 
Prazni, sterilni vsebniki
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu 
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http://www.emea.europa.eu
Risk of overdose is negligible owing to the type of formulation and administration (single dose implant for subcutaneous administration). 
Tveganje prevelikega odmerka je neznatno zaradi oblike pripravka in načina dajanja (enoodmerni implantat za podkožno dajanje).
Inject intraperitoneally along the central line, 1/2 to 1 fin length in front of the pelvic fin base. 
Injiciramo intraperitonealno vzdolž osrednje linije, 1/2 do 1 dolžino plavuti pred osnovo pelvične plavuti.
To minimise this problem, caution needs to be exercised to ensure that the implant is administered by subcutaneous injection, particularly in dogs with pronounced depots of subcutaneous fat. 
Da bi to težavo kolikor je možno zmanjšali, moramo poskrbeti, da se implantat vnese s podkožno injekcijo, zlasti pri psicah z izrazitim podkožnim maščevjem.
The implant may be administered to bitches from the age of four months. 
Implantat lahko uporabimo pri psicah od starosti štirih mesecev.
As a consequence, there is no follicular follicle growth (hence no oestrus is observed) and no ovulation. 
Posledica tega je, da preneha folikularna rast (zato se estrus ne pojavi) in ne pride do ovulacije.
If a bitch becomes pregnant following induced heat, embryonic resorption or abortion may occur. 
Če postane psica breja po spodbujeni gonitvi, lahko pride do resorpcije zarodkov ali splava.
Gonazon 18.5 mg implant for dogs 
Gonazon 18,5 mg, implantat za pse
VIAL CONTAINING CONCENTRATE: 
VIALA S KONCENTRATOM:
However, interactions with other medicinal products have not been investigated. 
Toda medsebojno delovanje z drugimi zdravili ni raziskano.
In addition following a repeat treatment, the timing of a return to heat cannot be accurately predicted. 
Poleg tega po ponovljenem zdravljenju ne moremo natančno napovedati ponovne gonitve.
In adult bitches, heat is commonly induced in the first month following the first administration of the implant. 
Pri odraslih psicah se gonitev običajno pojavi prvi mesec po prvem vnosu implantata.
Do not use Gonazon before approximately 10% of the specific broodstock population has ovulated naturally. 
Gonazona ne smemo uporabiti, preden ne pride do naravne ovulacije pri približno 10 % specifičnih plemenskih rib.
Gonazon implant is a solid, off white, 14x3x1 mm implant. 
Implantat Gonazon je trden implantat skoraj bele barve velikosti 14x3x1 mm.
Following a single administration, return to ovarian activity after implant removal may take longer in bitches treated before puberty (average 255 days, range 36-429 days) than in adult bitches (average 68 days, range 12 to 264 days). 
Pri enkratni uporabi se lahko delovanje jajčnikov po odstranitvi implantata pri psicah, ki jim vnesemo implantat pred puberteto, povrne po daljšem času (povprečno 255 dni; razpon 36-429 dni) kot pri odraslih psicah (povprečno 68 dni; razpon 12-264 dni).
Implant 
Implantat
Based on field data, the occurrence of oestrus after a single treatment was prevented for 12 months or more in 75% of treated adult bitches and  90 % of treated prepubertal bitches. 
Po podatkih s terena je preprečevanje estrusa po enkratni uporabi trajalo 12 mesecev ali dlje pri 75 % odraslih psic in pri  90 % psic pred puberteto.
For subcutaneous administration. 
Za subkutana uporaba.
Dog (bitches) 
Psi (psice)
Unlike liquid injections, there is no need to remove air bubbles as attempts to do so may displace the implant from the needle. 
Za razliko od tekočih injekcijskih pripravkov zračnih mehurčkov ni treba odstraniti, ker bi lahko pri tem implantat izpadel iz igle.
Manufacturer responsible for the batch release: Intervet GesmbH 
Izdelovalec, odgovoren za sproščanje serij: Intervet GesmbH
Chemical restraint (sedation and/or general anaesthesia) may be required for implant removal. 
Za odstranitev implantata je lahko potrebna umiritev z zdravili (sedacija in/ali splošna anestezija).
Azagly-nafarelin is a peptide that is primarily degraded by peptidases and not by cytochrome P-450 enzymes. 
Azagli-nafarelin je peptid, ki ga pretežno razgrajujejo peptidaze in ne encimi P-450.
Take care to avoid penetrating the abdominal wall musculature or fat tissue. 
Pazite, da ne bi predrli mišičja abdominalne stene ali maščevja.
The frequency of induced heat is lower when the first treatment is administered in metoestrus (32%) than in anoestrus (84%). 
Pogostnost spodbujene gonitve je manjša, če ga prvič vnesemo v metestrusu (32 %) kot če ga vnesemo v anestrusu (84 %).
Absorption: Following subcutaneous administration of a single implant to dogs (approximate weight of 10 kg), maximum serum concentrations (0.13 µg/ml) of azagly-nafarelin are reached around 3.5 hours. 
Absorpcija: Po subkutana uporaba vnosu enega implantata psom (težkim približno 10 kg) doseže azagli-nafarelin največjo koncentracijo v serumu (0,13 µg/ml) približno v 3,5 ure.
Accidental ingestion of the implant by the dog will not affect its health, since the oral bio-availability of GnRH agonists is very low. 
Nenamerno zaužitje implantata ne vpliva na zdravje psice, ker je peroralna biološka uporabnost agonistov GnRH zelo majhna.
In a limited laboratory study, co-administration of Gonazon and short-acting progestagens has been shown to be well tolerated. 
V manjši laboratorijski študiji je bilo prenašanje sočasne uporabe Gonazona in kratkodelujočih progestagenov dobro.
However, it should be noted that within the first month after treatment a proportion of treated bitches also experienced an induced heat (see section 4.5). 
Omeniti pa je treba, da imelo v prvem mesecu po uporabi določeno število psic spodbujeno gonitev (glejte poglavje 4.5).
Azagly-nafarelin Annex II for Salmonidae 
Substanca azagli-nafarelin Dodatek II za Salmonidae
Induced heat is not observed if treatment is started before puberty. 
Spodbujena gonitev se ne pojavi pri uporabi pred puberteto.
2 ml concentrate vials 
Viale s koncentratom po 2 ml
* this volume will be minimized for the species with the largest body weights. 
*Volumen zmanjšamo na minimum za vrste rib z največjo telesno maso.
One implant. 
En implantat
Cured elastomer, resulting from the polymerisation of polydimethylsiloxane and tetrapropylorthosilicate in the presence of stannous octoate. 
Zamrežen elastomer, pridobljen s polimerizacijo polidimetilsiloksana in tetrapropilortosilikata v prisotnosti kositrnega oktoata.
Carton: 1 concentrate vial and 1 solvent vial. 
Kartonska zloženka: 1 viala s koncentratom in 1 viala z vehiklom.
Laboratory studies have shown that administration of the product during early pregnancy in the bitch is unlikely to affect that pregnancy (that is, pregnancy will be carried to full term with the birth of viable pups). 
Laboratorijske študije so pokazale, da je malo verjetno, da bi uporaba izdelka v zgodnji brejosti pri psicah vplivala na brejost (psica bo donosila in skotila za življenje sposobne mladiče).
The empty, sterile vial is intended to be used for mixing the concentrate and solvent. 
Prazna, sterilna viala je namenjena za mešanje koncentrata in topila.
In bitches where gonadal function has been successsfully prevented for a period of 12 months, then a second treatment may be administered at that time for continued prevention of oestrus. 
Pri psicah, pri katerih je uporaba 12 mesecev uspešno preprečevala gonadno funkcijo, lahko po preteku tega obdobja izdelek ponovno uporabimo, da bi nadalje preprečili pojav estrusa.
Dog (bitches). 
Pes (psice)
It controls reproduction in fish by modulating the secretion of the pituitary gonadotrophins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), also known in fish endocrinology as GtH-II and GtH-I, respectively. 
Pri ribah uravnava reprodukcijo, tako da spreminja izločanje hipofiznih gonadotropinov, luteinizirajočega hormona (LH) in folikle stimulirajočega hormona (FSH), ki ju v endokrinologiji rib imenujemo tudi GtH-II in GtH-I.
GnRH is synthesised by neurones in the hypothalamus in all vertebrate species. 
GnRH sintetizirajo nevroni v hipotalamusu pri vseh vretenčarjih.
However, based on field trial data, the incidence of pseudopregnancy in treated bitches is not greater than in control (untreated) bitches. 
Toda podatki terenskih študij kažejo, da pogostnost namišljene brejosti pri zdravljenih psicah ni večja kot pri psicah v kontrolni skupini (nezdravljenih).
Female salmonid fish such as Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), brown trout (Salmo trutta) and Arctic charr (Salvelinus alpinus). 
Plemenke salmonidnih rib, kot so atlantski losos (Salmo salar), kalifornijska postrv ali šarenka (Oncorhynchus mykiss), rjava postrv (Salmo trutta) in jezerska zlatovčica (Salvelinus alpinus).
Pharmacotherapeutic group: Gonadotrophin-Releasing Hormone (GnRH) ATCvet code: QH01CA 
Farmakoterapevtska skupina: gonadotropin sproščajoči hormon (GnRH) Oznaka ATCvet: QH01CA
Store and transport at 2C - 8C (in a refrigerator). 
Shranjujte in prevažajte pri temperaturi 2C-8 C (v hladilniku).
The implant may not be retained in a proportion (1.2%) of treated bitches. 
Implantat pri določenem deležu (1,2 %) psic ne ostane na mestu.